Relugolix 737789-87-6

Ibisobanuro bigufi:

Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
Ribociclib CAS: 737789-87-6 Antineoplastique Mu nzu      


Ibisobanuro birambuye

Ibiranga ibicuruzwa

KUBONA UMUSARURO

Relugolix ikoreshwa mu kuvura kanseri ya prostate kubagabo.
Amazina y'ibirango: Orgovyx
Icyiciro cyibiyobyabwenge: Antineoplastique - LHRH (GnRH) Antagonist Pitoito Suppressants
Kuboneka: Ibisabwa
Inda: Baza muganga wawe.Iyi miti irashobora kugirira nabi umwana utaravuka.
Konsa: Baza muganga mbere yo gukoresha

Relugolix ni umunwa uboneka, udafite peptide gonadotropine irekura imisemburo (GnRH cyangwa luteinizing hormone irekura imisemburo (LHRH)), hamwe nibikorwa bya antineoplastique.Relugolix irushanwe guhuza no guhagarika reseptor ya GnRH muri glande y'imbere ya pitoito, byombi birinda GnRH guhuza reseptor ya GnRH kandi ikabuza gusohora no kurekura imisemburo ya luteinizing (LH) hamwe na hormone ikangura imisemburo (FSH).Ku bagabo, kubuza gusohora kwa LH birinda irekurwa rya testosterone muri selile ya Leydig.Kubera ko testosterone isabwa kugirango ikure ya prostate, kugabanya urugero rwa testosterone birashobora kubuza kanseri ya prostate iterwa na hormone.

Relugolix ni gonadotropine irekura imisemburo (GnRH) reseptor antagonist ikoreshwa mukuvura imisemburo myinshi ititabira imisemburo.Byemejwe bwa mbere mu Buyapani mu 2019, ku izina rya Relumina, kugira ngo bivure ibimenyetso bya fibroide nyababyeyi, kandi vuba aha na FDA yo muri Amerika muri 2020, ku izina rya Orgovyx, kugira ngo bivure kanseri ya prostate yateye imbere.Relugolix nayo yize mubuvuzi bwa endometriose.Relugolix niyambere (kandi kurubu gusa) itangwa kumanwa GnRH reseptor antagonist yemerewe kuvura kanseri ya prostate - imiti isa na [degarelix] isaba ubuyobozi bwimbuto - bityo ikaba itanga uburyo bworoshye bwo kuvura abarwayi bashobora gusaba gusurwa kwa muganga. kubuyobozi ninzobere mubuzima.Usibye kuba byoroshye gukoresha-gukoresha, relugolix yerekanwe ko isumba iyindi yo kwiheba kwa testosterone ugereranije na [leuprolide], ubundi buryo bwo kuvura androgene bukoreshwa mu kuvura kanseri ya prostate.

Relugolix ni Gonadotropine Irekura Hormone Receptor Antagonist.Uburyo bwibikorwa bya relugolix ni nka Gonadotropine Irekura Antagonist ya Hormone, na Cytochrome P450 3A Inducer, na Cytochrome P450 2B6 Inducer, hamwe na Inhibitor ya P-Glycoprotein.Ingaruka ya physiologic ya relugolix nuburyo bwo Kugabanuka kwa GnRH.

Imiterere yimiti

ghdfg

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

Gucunga neza

Quality management1

Icyifuzo18Imishinga yo gusuzuma ireme ryemejwe4, na6imishinga iremezwa.

Quality management2

Sisitemu mpuzamahanga yo gucunga neza ubuziranenge yashyizeho urufatiro rukomeye rwo kugurisha.

Quality management3

Igenzura ryiza rinyura mubuzima bwose bwibicuruzwa kugirango hamenyekane ingaruka nziza nubuvuzi.

Quality management4

Itsinda ryumwuga ushinzwe kugenzura ibikorwa byujuje ubuziranenge mugihe cyo gusaba no kwiyandikisha.

Gucunga UMUSARURO

cpf5
cpf6

Koreya Countec Amacupa yo gupakira

cpf7
cpf8

Tayiwani CVC Icupa ryuzuye

cpf9
cpf10

Ubutaliyani CAM Ubuyobozi bwo gupakira

cpf11

Imashini yo Kudage Fette

cpf12

Ubuyapani Viswill Tablet Detector

cpf14-1

Icyumba cyo kugenzura DCS

UMUFATANYABIKORWA

Ubufatanye mpuzamahanga
International cooperation
Ubufatanye mu ngo
Domestic cooperation

  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze